Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

January 2010
1. CHECK JH , Sansoucie L, Chern J, Dix E, et al
   Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.
   Anticancer Res. 2010;30:119-22.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. ZHANG S , Togo S, Minakata K, Gu T, et al
   Distinct roles of cholinergic receptors in small cell lung cancer cells.
   Anticancer Res. 2010;30:97-106.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
3. EL SHAROUNI SY , Kal HB, Barten-Van Rijbroek A, Struikmans H, et al
   Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
   Anticancer Res. 2009;29:5219-24.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
4. NISMAN B , Biran H, Ramu N, Heching N, et al
   The Diagnostic and Prognostic Value of ProGRP in Lung Cancer.
   Anticancer Res. 2009;29:4827-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. PANANI AD , Maliaga K, Babanaraki A, Bellenis I, et al
   Numerical Abnormalities of Chromosome 9 and p16CDKN2A Gene Deletion Detected by FISH in Non-small Cell Lung Cancer.
   Anticancer Res. 2009;29:4483-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
6. KARAPANAGIOTOU EM , Boura PG, Papamichalis G, Konstantinou M, et al
   Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study.
   Anticancer Res. 2009;29:4297-301.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MOON YW , Sohn JH, Kim YT, Chang H, et al
   Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA)-guided versus Empirical Chemotherapy in Unresectable Non-small Cell Lung Cancer.
   Anticancer Res. 2009;29:4243-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MARUYAMA R , Wataya H, Seto T, Ichinose Y, et al
   Treatment after the Failure of Gefitinib in Patients with Advanced or Recurrent Non-small Cell Lung Cancer.
   Anticancer Res. 2009;29:4217-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. AL-SAAD S , Donnem T, Al-Shibli K, Persson M, et al
   Diverse Prognostic Roles of Akt Isoforms, PTEN and PI3K in Tumor Epithelial Cells and Stromal Compartment in Non-small Cell Lung Cancer.
   Anticancer Res. 2009;29:4175-83.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MIURA N , Yano T, Shoji F, Kawano D, et al
    Clinicopathological Significance of Sip1-associated Epithelial Mesenchymal Transition in Non-small Cell Lung Cancer Progression.
    Anticancer Res. 2009;29:4099-106.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. FRESE S , Schuller A, Frese-Schaper M, Gugger M, et al
    Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer.
    Anticancer Res. 2009;29:2905-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. OCHSENREITHER S , Marnitz-Schultze S, Schneider A, Koehler C, et al
    Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charite.
    Anticancer Res. 2009;29:3411-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CABIBI D , Zerilli M, Caradonna G, Schillaci L, et al
    Diagnostic and prognostic value of CD10 in peripheral nerve sheath tumors.
    Anticancer Res. 2009;29:3149-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. MALONEY SC , Marshall JC, Antecka E, Orellana ME, et al
    SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
    Anticancer Res. 2009;29:3059-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. WANG CZ , Li XL, Sun S, Xie JT, et al
    Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer Res. 2009;29:2927-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
16. YAMASHITA S , Chujo M, Moroga T, Anami K, et al
    DYRK2 Expression May be a Predictive Marker for Chemotherapy in Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:2753-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SHUKUYA T , Takahashi T, Tamiya A, Ono A, et al
    Gefitinib Plus Paclitaxel after Failure of Gefitinib in Non-small Cell Lung Cancer Initially Responding to Gefitinib.
    Anticancer Res. 2009;29:2747-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. TOMITA M , Shimizu T, Hara M, Ayabe T, et al
    Preoperative Leukocytosis, Anemia and Thrombocytosis Are Associated with Poor Survival in Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:2687-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. MIYAZAKI K , Satoh H, Kurishima K, Nakamura R, et al
    Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:2671-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SHINGYOJI M , Ando S, Nishimura H, Nakajima T, et al
    VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel.
    Anticancer Res. 2009;29:2635-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. LAI JC , Wu JY, Cheng YW, Yeh KT, et al
    O6-Methylguanine-DNA Methyltransferase Hypermethylation Modulated by 17{beta}-Estradiol in Lung Cancer Cells.
    Anticancer Res. 2009;29:2535-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SAFRANEK J , Pesta M, Holubec L, Kulda V, et al
    Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in Lung Tissue of Patients with Non-small Cell Lung Cancer (NSCLC) and Benign Pulmonary Disease.
    Anticancer Res. 2009;29:2513-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. PESEK M , Benesova L, Belsanova B, Mukensnabl P, et al
    Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
    Anticancer Res. 2009;29:2767-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GARASSINO MC , Borgonovo K, Rossi A, Mancuso A, et al
    Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Anticancer Res. 2009;29:2691-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TSUNA M , Kageyama S, Fukuoka J, Kitano H, et al
    Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma.
    Anticancer Res. 2009;29:2547-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. NIKOLOVA T , Christmann M, Kaina B
    FEN1 is Overexpressed in Testis, Lung and Brain Tumors.
    Anticancer Res. 2009;29:2453-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
27. AGACHAN B , Kucukhuseyin O, Aksoy P, Turna A, et al
    Apurinic/Apyrimidinic Endonuclease (APE1) Gene Polymorphisms and Lung Cancer Risk in Relation To Tobacco Smoking.
    Anticancer Res. 2009;29:2417-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. KUSUMOTO S , Sugiyama T, Ando K, Hosaka T, et al
    Combination Effect between Bortezomib and Tumor Necrosis Factor {alpha} on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines.
    Anticancer Res. 2009;29:2315-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. GAO Z , Xu Z, Hung MS, Lin YC, et al
    Promoter Demethylation of WIF-1 by Epigallocatechin-3-gallate in Lung Cancer Cells.
    Anticancer Res. 2009;29:2025-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. MURUGAN RS , Vinothini G, Hara Y, Nagini S, et al
    Black Tea Polyphenols Target Matrix Metalloproteinases, RECK, Proangiogenic Molecules and Histone Deacetylase in a Rat Hepatocarcinogenesis Model.
    Anticancer Res. 2009;29:2301-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HUANG YW , Wang LS, Dowd MK, Wan PJ, et al
    (-)-gossypol reduces invasiveness in metastatic prostate cancer cells.
    Anticancer Res. 2009;29:2179-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. RAUSCH MP , Hahn T, Ramanathapuram L, Bradley-Dunlop D, et al
    An Orally Active Small Molecule TGF-{beta} Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer.
    Anticancer Res. 2009;29:2099-109.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. RICE SD , Bush JE, Brower SL
    Assessment of erlotinib in chemoresponse assay.
    Anticancer Res. 2009;29:1993-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. PFRAGNER R , Behmel A, Hoger H, Beham A, et al
    Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid.
    Anticancer Res. 2009;29:1951-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. WARENIUS H , Kyritsi L, Grierson I, Howarth A, et al
    Spontaneous regression of human cancer cells in vitro: potential role of disruption of Cdk1/Cdk4 co-expression.
    Anticancer Res. 2009;29:1933-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
36. HIROSE T , Sugiyama T, Kusumoto S, Shirai T, et al
    Phase II Study of the Combination of Nedaplatin and Weekly Paclitaxel in Patients with Advanced Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:1733-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KIM Y , Kim HS, Cui ZY, Lee HS, et al
    Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.
    Anticancer Res. 2009;29:1817-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ZUPA A , Sgambato A, Bianchino G, Improta G, et al
    GSTM1 and NAT2 Polymorphisms and Colon, Lung and Bladder Cancer Risk: A Case-control Study.
    Anticancer Res. 2009;29:1709-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. TERPOS E , Kiagia M, Karapanagiotou EM, Charpidou A, et al
    The clinical significance of serum markers of bone turnover in NSCLC patients: surveillance, management and prognostic implications.
    Anticancer Res. 2009;29:1651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. MURTHAIAH P , Truskinovsky AM, Shah S, Dudek AZ, et al
    Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features of colonic and lung primary tumors.
    Anticancer Res. 2009;29:1495-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
41. KATSIMPOULA S , Patrinou-Georgoula M, Makrilia N, Dimakou K, et al
    Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer.
    Anticancer Res. 2009;29:1373-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. GRIMMINGER P , Ling FC, Neiss S, Vallbohmer D, et al
    The Role of the Homeobox Genes BFT and CDX2 in the Pathogenesis of Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:1281-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. METZGER R , Vallbohmer D, Muller-Tidow C, Higashi H, et al
    Increased Human Telomerase Reverse Transcriptase (hTERT) mRNA Expression but not Telomerase Activity is Related to Survival in Curatively Resected Non-small Cell Lung Cancer.
    Anticancer Res. 2009;29:1157-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SHEN C , Liu W, Buck AK, Reske SN, et al
    Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
    Anticancer Res. 2009;29:1423-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
45. HSU NY , Wang HC, Wang CH, Chiu CF, et al
    Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan.
    Anticancer Res. 2009;29:725-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SU JM , Lin P, Wang CK, Chang H, et al
    Overexpression of cytochrome P450 1B1 in advanced non-small cell lung cancer: a potential therapeutic target.
    Anticancer Res. 2009;29:509-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. BODNER-ADLER B , Bartl M, Wagner G
    Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Anticancer Res. 2009;29:495-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
48. SPONRING A , Filipiak W, Mikoviny T, Ager C, et al
    Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
    Anticancer Res. 2009;29:419-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. DE JONG WK , Verpooten GF, Kramer H, Louwagie J, et al
    Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer.
    Anticancer Res. 2009;29:363-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HSIA TC , Yang JS, Chen GW, Chiu TH, et al
    The roles of endoplasmic reticulum stress and Ca2+ on rhein-induced apoptosis in A-549 human lung cancer cells.
    Anticancer Res. 2009;29:309-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. SCHMIDT LH , Biesterfeld S, Kummel A, Faldum A, et al
    Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue.
    Anticancer Res. 2009;29:201-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ZHANG C , Lv F, Zhou L, Li X, et al
    Effect of verapamil on the expression of EGFR and NM23 in A549 human lung cancer cells.
    Anticancer Res. 2009;29:27-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. THOM I , Schult-Kronefeld O, Burkholder I, Schuch G, et al
    Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases.
    Anticancer Res. 2009;29:249-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
54. CATALANO G , De Pas T, Spaggiari L, Gandini S, et al
    Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. WU C , Jiang J, Shi L, Xu N, et al
    Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. LEONE JP , Dudek AZ
    Enzyme replacement therapy for Gaucher's disease in patient treated for non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. IGAWA S , Takahashi T, Nakamura Y, Tsuya A, et al
    Efficacy of amrubicin for non-small cell lung cancer after failure of two or more prior chemotherapy regimens.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. GRANT WB
    Skin aging from ultraviolet irradiance and smoking reduces risk of melanoma: epidemiological evidence.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. MEYER A , Steinmann D, Malaimare L, Karstens JH, et al
    Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
60. WOJCIK E , Kulpa JK, Sas-Korczynska B, Korzeniowski S, et al
    ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. SUROWIAK P , Pawelczyk K, Maciejczyk A, Pudelko M, et al
    Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. TELL R , Sederholm C, Klintenberg C, Franksson L, et al
    Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. KANEMOTO K , Satoh H, Ishikawa H, Kagohashi K, et al
    Diagnostic procedures for small pulmonary nodules detected by mass-screening.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. DUDEK AZ , Nguyen S
    Safety of nab-paclitaxel plus sunitinib: analysis of three cases.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. NIEDER C , Geinitz H, Molls M
    Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. IMPROTA G , Sgambato A, Bianchino G, Zupa A, et al
    Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. CALZOLARI F , Sartori PV, Talarico C, Parmeggiani D, et al
    Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
68. ARDAVANIS A , Koumna S, Fragos I, Malliou S, et al
    Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. DAHSE R , Berndt A, Kosmehl H
    PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. INAMURA K , Togashi Y, Ninomiya H, Shimoji T, et al
    HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. SAKAYAMA K , Tauchi H, Sugawara Y, Kidani T, et al
    A complete remission of sclerosing rhabdomyosarcoma with multiple lung and bone metastases treated with multi-agent chemotherapy and peripheral blood stem cell transplantation (PBSCT): a case report.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. LIU Y , Lan Q, Shen M, Jin J, et al
    Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. SADAHIRO S , Suzuki T, Maeda Y, Tanaka A, et al
    Long-term postoperative adjuvant chemotherapy of UFT/LV improves survival in a primary tumor resection-pulmonary metastasis model.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
74. OHRLING K , Edler D, Hallstrom M, Ragnhammar P, et al
    Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: